Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
59,421,648
-
Shares change
-
+2,800,784
-
Total reported value, excl. options
-
$762,327,973
-
Value change
-
+$32,572,198
-
Put/Call ratio
-
76%
-
Number of buys
-
75
-
Number of sells
-
-51
-
Price
-
$12.83
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2018
145 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2018.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,421,648 shares
of 114,331,829 outstanding shares and own 51.97% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (10,359,666 shares), FMR LLC (7,380,302 shares), BlackRock Inc. (5,031,783 shares), FRANKLIN RESOURCES INC (3,244,706 shares), Casdin Capital, LLC (2,550,000 shares), Vanguard Group Inc (2,541,990 shares), FARALLON CAPITAL MANAGEMENT LLC (2,200,000 shares), Artal Group S.A. (2,150,000 shares), ARCH VENTURE CORP (2,073,190 shares), and STATE STREET CORP (2,033,588 shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.